Preprint
Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
Abstract
Importance: Major depressive disorder (MDD) is a heterogeneous clinical syndrome with widespread subtle neuroanatomical correlates. Identifying neuroimaging-based biomarkers might aid in defining the disease-related dimensions that characterize MDD and predict treatment response.
Objective: To investigate the neuroanatomical dimensions that characterize MDD and predict treatment response to selective serotonin reuptake inhibitor (SSRI) …
Authors
Antoniades M; Fu C; Erus G; Garcia J; Fan Y; Arnone D; Arnott S; Chen T; Choi KS; Fatt CC
DOI
10.21203/rs.3.rs-2289671/v1
Preprint server
Research Square